01 1Patheon Italia S.p.A.
02 1Takeda Pharmaceutical Company Limited
01 1VEDOLIZUMAB
02 1Vedolizumab
01 1Japan
02 1U.S.A
NDC Package Code : 68225-240
Start Marketing Date : 2014-05-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (300mg/5mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
NDC Package Code : 11532-3002
Start Marketing Date : 2014-05-20
End Marketing Date : 2024-12-31
Dosage Form (Strength) : INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION (300mg/1)
Marketing Category : DRUG FOR FURTHER PROCESSING
We have 2 companies offering Vedolizumab
Get in contact with the supplier of your choice:
